Screenings can detect cancer and precancerous lesions in its early stages when it’s at its most treatable, according to a Feb. 16 news release. The five-year survival rate for colorectal cancer when caught early is 90 percent, but that number drops to 14 percent when diagnosed at stage 4.
Salt Lake City-based Intermountain Healthcare saw a nearly 50 percent decrease in colorectal screenings across its healthcare system from 2019-20.
“Delays in screening could mean that the missed cancers might be larger and more advanced,” Holly Clark, MD, gastroenterologist at Intermountain Heber Valley and Park City Hospitals, said. “Cancers, in general, are easier to treat in their early stages and early detection could mean a difference between life and death.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
